Malignant Thymus Neoplasm — Trials

Malignant Thymus Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

193 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 80
Recruiting: 43
Ph III recruiting: 1
Growth YoY: —
Industry share: 23%
Top sponsor: Jonsson Comprehensive Cancer Center
Termination share: 30.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (22)

clinicaltrialsPublishedShowing 51–55 of 55 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06796517	Immunotherapy in Lymphoma	recruiting	—	72	Sung-Soo ParkOTHER	1	Jan 28, 2025	clinicaltrials
NCT06238648	Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy	recruiting	Phase 2	120	Academic and Community Cancer Research UnitedOTHER	1	Sep 26, 2024	clinicaltrials